This webinar reveals results from a recent industry survey that sought to gain insight on trial sponsors’ perspective on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so. Register now to learn more.
Each year, PwC's Health Research Institute (HRI) names the top issues for the health industry in the coming year. What made the list for 2020? Join HRI for a discussion of the most important trends for providers, insurers, pharma/life sciences and employers. Register now.
Are there certain types of clinical sponsors and studies that are at greater risk of experiencing supply challenges? This webinar will explore aspects of the study protocol that can directly influence clinical supply strategy and how sponsors can proactively understand and address clinical supply-related risks. Register now.
Obtaining feedback from Life Sciences organizations are key in the delivery of actionable insights that our target customers come to expect. Our goal is to assess how far the adoption of AI technology has come in Life Sciences. Let your voice be heard in this survey.
In this whitepaper, we look at robust strategies that pharmaceutical manufacturers can adopt to protect their supply chain. Innovative solutions, such as on-dose microtags, are now being used to authenticate products; this mitigates counterfeiting, product diversion and helps to monitor returned product, quality control and recall. Download the whitepaper to learn more!
From the basics such as service level expectations for couriers versus integrators, to how to evaluate domestic and international lanes, and finally – how to balance risk and cost, this webinar will help you understand how to start tackling your clinical supply chain. Register now.
Drug development is an increasingly challenging industry with R&D returns declining, regulatory hurdles increasing, and the competition for funding ever fierce. Metabolomics is an essential technology for helping you overcome these challenges by bringing a focused approach to your data discovery while uncovering actionable insights. Read the whitepaper today!
Join us as an interdisciplinary group of experts from the Digital Medicine Society (DiMe) provide a brief introduction to core concepts and terms that define digital medicine, along with practical tips for implementation and case examples.
Today, the rise of a new generation of robotic, precision, and surgical devices has created vast stores of video, imaging, and electronic surgical notes, prompting the question: How do you leverage these datasets and improve patient treatments and outcomes? Register now to learn how a connected data platform offers a definitive answer.
This whitepaper highlights the challenges of implementing the right digital twin strategy while providing key use cases in the manufacturing domain for which a digital twin is extremely useful and several examples of technology trends that will shape the future. Download now.
Why should the primary container system be considered an excipient? Register for West’s webinar on December 5, to gain insight on considerations that should be made to mitigate packaging risks early in the drug development process!
In this webinar, AstraZeneca and Catalent Biologics experts will share a case study on a 30-day commercial launch plan for a product into new markets and why this approach was important for patients. Register now.
Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management. Learn how to reap the rewards of a straightforward build and a modern EDC during this webinar. Register now.
Get your copy of the Q2 2019 Life Sciences M&A notes and trends. You’ll get insights like:
- The top 11 M&A deals with values over $500 million
- Oncology deals spend and breakdown
- Why AbbVie led the M&A activity in the biopharmaceutical sector
- 5 year Allergan launch activity expected to close at the beginning of 2020
Drug developers must be prepared to react to changes in their API’s quality attributes, even if the synthesis used at a small scale is the same one used at a large scale. If undesirable effects occur that negatively impact API scale-up, it can prevent a company from delivering a product with reliable quality and efficacy. Click here to learn more!
When payers insert themselves into the clinical decision-making process, it can diminish the trust and confidence patients have in their healthcare providers. Download this complimentary paper that explores the practice of step therapy and its impact on key stakeholders in the US healthcare system.
In this Q&A, four Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the success of a biologic when embarking upon the commercial manufacturing journey. Click here to learn more!
It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers. Download this whitepaper now to learn more about prescription drug price transparency and its role in creating affordability, accessibility, and accountability.
Accenture experts will explore the emergence of SaMD as a new class of medical device and discuss the potential challenges that biopharma companies face in the development of these solutions. Register for this webinar now.
Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. At the same time, they must meet GxP requirements, update antiquated systems and processes, and address the demands of an increasingly tech savvy workforce. Register now to learn more about the role that content management plays in pharmaceutical manufacturing.
The global landscape study identifies and assesses innovative funding models for cancer and other high-cost chronic NCDs across Africa, Asia, Europe, Latin America and Middle East. The study aims to enable readers to better understand the possibilities that innovative funding models bring to bridge the current and future funding gap,while stressing the key success factors that enable sustainability and success such as stakeholder collaboration. Click here to download the whitepaper!
The increasing global adoption of electronic medical records (EMRs) at clinical sites has prompted interest in using sites’ EMRs systematically for observational studies. Discover the benefits and challenges, both technical and operational, of implementing site-based EMR studies in this white paper. Read now.
Managing the volume and variability of healthcare data is a challenge for many life sciences organizations looking to modernize clinical trials. From data management to IoT to high-performance computing and machine learning, life sciences organizations are working with Amazon Web Services (AWS) and AWS Partners to develop life science solutions that are scalable, global, and secure. Click here to download the eBook!
This whitepaper explores how a data lake, enabled by AI and ML, can be used to ingest, aggregate, standardize and provide secured data access and the value it can deliver in reducing risk and driving efficiency, speed and cost savings. Download now.
Liquid-filled capsule technology has a proven record for addressing complex API formulation challenges, but also offers a simple and effective pathway to the clinic. Register now to learn more about lipid-based formulations.
Join industry experts as they analyze the critical role of innovation in OTC products, and strategies for achieving it. Register now to learn more about survey insights, market trends, and latest technologies.
The transformations now taking place in the emerging field of connected packaging have the potential to address all these product challenges—protection, engagement, traceability—while delivering powerful supply chain insight. Register now to learn more.
Medical Affairs 2025 brings together leading perspectives from AstraZeneca, Bristol-Myers Squibb, Merck, Lilly, and other innovative life sciences organizations on key challenges impacting medical affairs and a roadmap for success in the coming decade. Download the whitepaper.
Why is diversity in clinical trials important? Minority populations are more likely to be diagnosed with certain cancers, stroke, diabetes, and are more likely to die prematurely than White Americans. Health disparities by race and ethnicity could increase if minority populations are not included in clinical trials.
Register now to learn who is participating in clinical trials and why.
By collaborating with industry experts on advanced technologies, we find new ways to help clinicians improve patients’ lives. IBM’s highlighted solutions reside in a security-rich cloud environment—home for capturing, managing and analyzing clinical study data with control, accuracy and confidence. These solutions lay the groundwork for further integration with IBM® Watson® cognitive technology.
Integrated Imaging and EDC ensures the right data is presented to the right users at the right time, free from manual intervention. Taking data reconciliation to a whole new level means your trial not only saves time, resources and cost, but also drastically reduces your clinical trial risk. Register now to learn more.
Inpatient View and Outpatient View are powered by robust data assets and use sophisticated projection methodologies to help ensure accuracy of reporting. This white paper is designed to demonstrate the utility of using the MarketScan® Inpatient View and Outpatient View online tools to efficiently size a market for a medical device or technology.
Acknowledging various stakeholder networks, as well as recognizing variances within the regulatory environment, can be essential for companies looking to uncover the right decision-makers in support of biologics or biosimilars. Download the whitepaper to learn more.
Fully integrated CDMO for biologics bulk drug substance and sterile injectable drug products. Benefit from our turnkey upstream and downstream support for eukaryotic, microbial and viral expression as well as finished dose services.
- Cell, Viral, and Microbial
- Single-Use Platform (2L to 4000L Scale)
- Process & Analytical Development
- Parenteral Formulation Development
- Fill/Finish Capabilities
- Vials & Pre-Filled Syringes
- Liquid & Lyophilized products
To learn more, visit us at CPhI WW, Stand 120A50 or contact us at [email protected]
When consistent supply for your patients is critical, you can rely on an ANI Global Source collaboration. ANI Global Source is a specialty CDMO supporting late stage development and commercial pharmaceutical manufacture of:
- Oral dosage forms
- Creams & Gels
- Potent compounds
- Class II controlled substances
Manufacturing your product requires more than raw materials and established processes. At ANI Global Source, expertise, safety, reliability, and integrity are at the core of everything we produce. Visit us at booth 121H63 to learn more.
In this webinar, we'll highlight some of these approaches and demonstrate how data and analytics can be used to gain a competitive advantage and create differentiation. Register now.
Formulation challenges. Clinical supply hurdles. Lifecycle management. Risk mitigation. Patent expiry concerns. At BioPharma Solutions, a business unit of Baxter, we know the high-stakes challenges you face in today’s complex parenteral marketplace — and how the work we do is vital to the patients you serve.
If you have an injectable molecule and are looking for sterile contract manufacturing services, we invite you to stop by our stand at CPhI Worldwide in Frankfurt (Hall 12.1, Space F81) to meet with a representative and discuss how we can help you achieve your molecule’s full potential. Learn more.
We assists clients with small molecule cGMP projects from lab to multi-metric ton quantities. Our team provides phase appropriate route and process development solutions for short-term scale-up and long-term manufacturing challenges.
With vast experience in downstream purification techniques (chromatography, crystallization), we have completed 100+ chemical API projects (10 ongoing commercial products), including: complex multi-step synthesis, potent handling, and controlled substances. FDA & Health Canada inspected.
To meet our team at CPhI (booth 121H42), email [email protected]!
Discover an approach to solubility and bioavailability enhancement of poorly water soluble drug molecules, approaches to aqueous-based spray drying of bio-pharmaceuticals as well as small molecules intended for inhalation delivery. Join us for this webinar to learn more.
Register for this webinar to learn about the tools and technologies for creating dosage forms such as orally disintegrating tablets (ODTs), multi-particulates, and modified release formulations.
In this interview, Greg Fry, Patient and Consumer Analytics - ZS Associates, discusses consumer data and marketing trends and how to optimize digital campaigns. Watch the video.
In this webinar, you will hear from Alan Louie, Ph.D, Research Director at IDC, Bill Swavely, CIO at Pharm-Olam, and Rama Kondru, Ph.D, CIO at Medidata about the need for a platform approach in clinical research, the rationale for switching from disparate systems to a unified platform, and the benefits that could be realized. Register now.
This webinar will address how the use of technology for deploying data and analytic standards can be utilized to meet the challenge of understanding and comparing findings between studies conducted by different researchers, by facilitating the standardization, transparency, reproducibility, and replicability of RWD research. Register now.
In this webinar, we'll share insights to harness the strategic value of real world data to build optimized drug development programs that minimize the time and cost of sponsor-driven studies. Register now!
Join us for this webinar as we bring together a panel of industry experts to discuss the changing landscape of biosimilar development and how it will affect pricing in the future.
With increasing competition for patients, the ability to effectively and efficiently execute on clinical development plans has increased focus on alternative data sources. In this one-hour session attendees will hear from former FDA leaders and industry experts who will address what Synthetic Control is and how it can be leveraged in clinical development.
As companies face pressure to bring drugs to market quicker & at minimal cost, pharma & biotech companies are outsourcing parts of drug development & manufacturing process. Outsourcing eliminates the need to maintain expensive in-house facilities & provides access to other technologies & expertise. Click here to download the whitepaper today!
Eight years after the FDA issued its guidance of process validation, some still ask the question “Is process characterization optional anymore?” This webinar will cover the basics of process characterization, whether it is optional or not, and what “good” process characterization really looks like. Register now!
In this industry, even small improvements to streamline R&D processes can lead to substantially higher revenue and lower costs. To achieve those goals, pharmaceutical companies need to leverage their massive data assets that include decades of research and clinical trial data. Download this whitepaper to learn more.
Developing a combination product? Join experts Susan Neadle, Sr. Director, Global Value Chain Quality Design, Johnson & Johnson and Jennifer Riter, Sr. Director, Lab Services, West to learn how you can create an effective risk management program. Register Now!
Hear from Moderna’s Chief Digital and Operational Excellence Officer how they have eliminated data siloes to accelerate data-driven decisions at an enterprise level, and established a production environment capable of consistent delivery of complex drug products including a “batch of one”. Register Now!
Patient influencers on social platforms like Facebook, Instagram and Twitter are driving high-value actions for brands, and pharma is no exception. Download our report to discover how influencers will help you boost brand trust and best practices for working with influencers.
This presentation will discuss how predictable stability and solubility can minimize development timelines and cost. Attend to hear about two case studies exemplifying the importance of understanding the hydration space of an API and how hydrate formation may be avoided by development of a robust crystallization procedure.
Please join the experts from CMIC Group, Japan’s largest CRO with over 30 years of analytical service experiences in US and Japan, to learn the insights and tips on developing an immunogenicity assay in a regulated laboratory, selecting a format for the neutralization assay for immunogenicity assessments, and quantitative Bioanalysis of Oligonucleotides by LC-MS. Register Now!
In this webinar, manufacturing experts will discuss the benefits of end-to-end solutions and share case studies on how flexible manufacturing strategies can accommodate the changing landscape of pharmaceutical products and help bring a drug to market. Register now!
Download this whitepaper to learn how developing a digitized, integrated lab environment can facilitate collaborations and take advantage of technological advancements like machine learning to streamline and automate workflows- making research more productive.